Differential effects of the Toll-like receptor 2 agonists, PGN and Pam3CSK4 on anti-IgE induced human mast cell activation

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Yu, Yangyang ^a,b   Yip, Kwok Ho ^b   Tam, Issan Yee San ^b   Sam, Sze Wing ^b   Ng, Chun Wai ^b   Zhang, Wei ^a   Lau, Hang Yung Alaster ^b  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA N ACETYLHEXOSAMINIDASE; CALCINEURIN; CYCLOSPORIN A; HETERODIMER; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR AGONIST; TRIPALMITOYL GLYCERO CYSTEINE (LYSINE) 4; UNCLASSIFIED DRUG; WORTMANNIN; ANTI-IGE ANTIBODIES; ANTIIDIOTYPIC ANTIBODY; CALCIUM; LIGAND; LIPOPEPTIDE; PAM(3)CSK(4) PEPTIDE;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL ACTIVATION; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DIMERIZATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MAST CELL; MAST CELL DEGRANULATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; AGONISTS; CELL LINE; CHEMISTRY; CYTOLOGY; DEGRANULATION; DOWN REGULATION; DRUG EFFECTS; DRUG POTENTIATION; INNATE IMMUNITY; METABOLISM;

ANTIBODIES, ANTI-IDIOTYPIC; CALCINEURIN; CALCIUM; CELL DEGRANULATION; CELL LINE; DOWN-REGULATION; DRUG SYNERGISM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-8; LIGANDS; LIPOPEPTIDES; MAST CELLS; PEPTIDOGLYCAN; RECEPTORS, IGE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84911931419     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112989     Document Type: Article

References (27)

1. Kasakura K, Takahashi K, Aizawa T, Hosono A, Kaminogawa S (2009) A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells. Int Arch Allergy Immunol 150: 359-369.
2. Yoshioka M, Fukuishi N, Iriguchi S, Ohsaki K, Yamanobe H, et al (2007) Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol 120: 452-461.
3. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA (2006) FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107: 610-618.
4. Lauener RP, Birchler T, Adamski J, Braun-Fahrlander C, Bufe A, et al (2002) Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 360: 465-466.
5. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, et al (2004) Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113: 482-488.
6. Takenaka H, Ushio H, Niyonsaba F, Jayawardana ST, Hajime S, et al (2010) Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands. Biochem Biophys Res Commun 391: 471-476.
7. Saluja R, Delin I, Nilsson GP, Adner M (2012) FcepsilonR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment. PLoS One 7: e43547.
8. Kawahara T (2010) Inhibitory effect of heat-killed Lactobacillus strain on immunoglobulin E-mediated degranulation and late-phase immune reactions of mouse bone marrow-derived mast cells. Anim Sci J 81: 714-721.
9. Sandig H, Bulfone-Paus S (2012) TLR signaling in mast cells: common and unique features. Front Immunol 3: 185.
10. Zhang M, Murphy RF, Agrawal DK (2007) Decoding IgE Fc receptors. Immunol Res 37: 1-16.
11. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
12. Lin HY, Tang CH, Chen YH, Wei IH, Chen JH, et al (2010) Peptidoglycan enhances proinflammatory cytokine expression through the TLR2 receptor, MyD88, phosphatidylinositol 3-kinase/AKT and NF-kappaB pathways in BV-2 microglia. Int Immunopharmacol 10: 883-891.
13. Askarian F, van Sorge NM, Sangvik M, Beasley FC, Henriksen JR, et al (2014) A Staphylococcus aureus TIR Domain Protein Virulence Factor Blocks TLR2- Mediated NF-kappaB Signaling. J Innate Immun 6: 485-498.
14. Gwack Y, Feske S, Srikanth S, Hogan PG, Rao A (2007) Signalling to transcription: store-operated Ca2 + entry and NFAT activation in lymphocytes. Cell Calcium 42: 145-156.
15. Gilfillan AM, Tkaczyk C (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6: 218-230.
16. Saturnino SF, Prado RO, Cunha-Melo JR, Andrade MV (2010) Endotoxin tolerance and cross-tolerance in mast cells involves TLR4, TLR2 and FcepsilonR1 interactions and SOCS expression: perspectives on immunomodulation in infectious and allergic diseases. BMC Infect Dis 10: 240.
17. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, et al (2000) Toll-like receptor 2- mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1: 533-540.
18. McCall-Culbreath KD, Li Z, Zhang Z, Lu LX, Orear L, et al (2011) Selective, alpha2beta1 integrin-dependent secretion of il-6 by connective tissue mast cells. J Innate Immun 3: 459-470.
19. Abel J, Goldmann O, Ziegler C, Holtje C, Smeltzer MS, et al (2011) Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake. J Innate Immun 3: 495-507.
20. Sumbayev VV, Yasinska I, Oniku AE, Streatfield CL, Gibbs BF. (2012) Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. Plos One 7(3): e34259.
21. Martin RJ (2006) Infections and asthma. Clin Chest Med 27: 87-98, vi.
22. Fuchs B, Knothe S, Rochlitzer S, Nassimi M, Greweling M, et al (2010) A Tolllike receptor 2/6 agonist reduces allergic airway inflammation in chronic respiratory sensitisation to Timothy grass pollen antigens. Int Arch Allergy Immunol 152: 131-139.
23. Taylor RC, Richmond P, Upham JW (2006) Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 117: 1148-1154.
24. Yu YY, Yip KW, Tam IYS, Sam SW, NG CW, et al (2013) Differential effects of the Toll-like receptor 2 agonists, PGN and Pam3CSK4 on substance P induced human mast cell activation. Eur J Inflamm 3: 709-718.
25. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, et al (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281: 31002-31011.
26. Shin SY, Yang HW, Kim JR, Heo WD, Cho KH (2011) A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network. J Cell Sci 124: 82-90.
27. Ishii KJ, Coban C, Akira S (2005) Manifold mechanisms of Toll-like receptorligand recognition. J Clin Immunol 25: 511-521.